Post-earnings recap
Reported
Wed, Oct 15, 2008
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Abbott Laboratories reported an EPS of $0.79, slightly beating expectations, but the stock fell by 1.6% after the announcement. The lack of revenue details and management commentary may have contributed to investor uncertainty, leading to the stock's decline.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.79 | N/A | +2.20% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—